Global Peripheral Vascular and Biliary Stents Market Size to Reach USD 7,405.9 Million in 2032 | Emergen Research

Increasing prevalence of cardiovascular and biliary diseases is a major factor driving Peripheral Vascular and Biliary Stents Market revenue growth

Vancouver, Dec. 19, 2023 (GLOBE NEWSWIRE) — The global peripheral vascular and biliary stents market size is expected to reach USD 7,405.9 Million in 2032 and register a revenue CAGR of 6.0% during the forecast period, according to the latest analysis by Emergen Research. Rising prevalence of cardiovascular and biliary diseases is one of the major factors driving the peripheral vascular and biliary stents market revenue growth. An estimated 8,000 individuals across the U.S. are diagnosed with bile duct cancer each year. A person with intrahepatic bile duct cancer is frequently identified at age 70. To avoid rising prevalence of biliary illnesses, biliary stents are becoming increasingly beneficial, which is driving market revenue growth. Peripheral vascular and biliary stents are in high demand due to the rise in minimally invasive treatments. An increasingly common method that allows for minimally invasive treatment of conditions that formerly required surgery is stenting. Vascular stents are typically implanted as part of peripheral artery angioplasty, a minimally invasive endovascular procedure to open up constrictive or blocked arteries or veins, frequently to treat arterial atherosclerosis.

The peripheral vascular and biliary stents face significant commercial limitations as a result of stringent regulatory clearance process. To get regulatory approval, these medical devices must meet strict safety and efficacy standards established by regulatory bodies. The lengthy and difficult approval process usually causes product launches to be postponed, which can restrain market revenue growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Scope of Research

Report Details Outcome
Market size in 2022 USD 4,124.6 Million
CAGR (2023-2032) 6.0%
Revenue forecast to 2032 USD 7405.9 Million
Base year for estimation 2022
Historical data 2019-2021
Forecast period 2023-2032
Quantitative units Revenue in USD Million and CAGR in % from 2023 to 2032
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends.
Segments covered Product type, material, end-use, region
Regional scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope U.S., Canada, Mexico, Germany, U.K., France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, Israel, Rest of MEA
Key companies profiled Abbott, BD, BIOTRONIK, Boston Medical Products Inc., Boston Scientific Corporation, Cook, Cordis, E. Benson Hood Laboratories, Inc., Medtronic, Merit Medical Systems
Customization scope 10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

Major Companies and Competitive Landscape

The global peripheral vascular and biliary stents market is fragmented, with several large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective peripheral vascular and biliary stents services. Some major players included in the global peripheral vascular and biliary stents market report are:

  • Abbott
  • BD
  • Boston Medical Products Inc.
  • Boston Scientific Corporation
  • Cook
  • Cordis
  • E. Benson Hood Laboratories, Inc.
  • Medtronic
  • Merit Medical Systems

Strategic Development

  • On 07 April 2023, the Stena Peripheral Flow Directing Stent was created by the Turkish medical company Invamed for the management of peripheral artery aneurysms. According to Invamed, these stents are adaptable to the walls of peripheral arteries since they are flexible, have a high bending capacity, and in addition, are fatigue resistant.
  • On 08 February 2023, Cardiovascular Systems, Inc. (CSI), a manufacturer of medical devices with a cutting-edge atherectomy system used to treat peripheral and coronary artery disease, and Abbott signed a formal agreement under which Abbott would acquire CSI. Abbott’s market-leading vascular device lineup will gain access to fresh, complementary innovations thanks to the purchase of CSI.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @

Some Key Highlights from the Report

  • On 08 February 2023, a formal agreement between Abbott and Cardiovascular Systems, Inc. (CSI), a producer of medical equipment with a cutting-edge atherectomy system used to treat coronary and peripheral artery disease, was struck. Considering the acquisition of CSI, Abbott’s market-leading vascular device range will have access to new, complementary breakthroughs.
  • The peripheral vascular stents segment is expected to register a steady revenue CAGR during the forecast period. Peripheral vascular disease is becoming more common, which is driving revenue growth of this segment. Other disorders such as diabetes or coronary artery disease are typically present in patients with chronic peripheral vascular disease. Peripheral stents are frequently implanted alongside balloon angioplasty. Implanting peripheral stents helps keep a blocked or clogged artery open so that blood can flow through it.
  • The metal stents segment is expected to account for a significantly large revenue share during the forecast period. Stainless steel 316L, stainless steel 316LVM, nitinol, cobalt-chromium, titanium, tantalum alloys, and platinum-iridium alloy are among the biocompatible materials frequently used to make stents. Precision laser cutting technology is used to cut the complicated lattice-like patterns required for their extraordinary growth capabilities.
  • The market in North America is expected to account for largest revenue share during the forecast period. The region is recognized for its state-of-the-art medical infrastructure and technological advancements, which allowed the introduction of revolutionary stent technology. Furthermore, considerable Research and Development (R&D) activities, collaborations between business and academic institutions, and presence of key market competitors in North America are driving revenue growth of the peripheral vascular and biliary stents market.

Segments Covered in Report

For the purpose of this report, Emergen Research has segmented the global peripheral vascular and biliary stents market on the basis of product type, material, end-use, and region:

  • Product Type Outlook (Revenue, USD Million; 2019–2032)                                            
    • Peripheral Vascular Stents
      1. Self-Expanding Stents
      2. Balloon-Expandable Stents
      3. Drug-Eluting Stents
      4. Bare Metal Stents
    • Biliary Stents
      1. Plastic Stents
      2. Metal Stents
      3. Drug-Eluting Stents
  • Material Outlook (Revenue, USD Million; 2019–2032)                                           
    • Metal Stents
      1. Stainless Steel
      2. Nitinol
      3. Cobalt-Chromium Alloy
    • Polymer Stents
      1. Biodegradable Polymer
      2. Non-Biodegradable Polymer
  • End-Use Outlook (Revenue, USD Million; 2019–2032)                                            
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • Regional Outlook (Revenue, USD Million, 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. Spain
      5. BENELUX
      6. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Israel
      4. Rest of MEA

Browse Full Report Description + Research Methodology + Table of Content + Infographics@  

Curated Reports You Shouldn’t Miss: Dive In Now!

Adherence Packaging Market By Type (Unit-dose Packaging Systems and Multi-dose Packaging Systems), By Material (Plastic, Paper & Paperboard, Aluminum), By End-use, and By Region Forecast to 2032

Clinical Laboratory Services Market, By Specialty (Clinical Chemistry Testing, Microbiology Testing, Hematology Testing, Immunology Testing, Cytology Testing, and Genetic Testing), By Provider, By Application, and By Region Forecast to 2032

Nerve Monitoring System Market, By Component (Software and Hardware), By Technology [Electromyography (EMG), Evoked Potential (EP), and Others], By Application (Neurosurgery, Spine Surgery, and Others), By End-Use, and By Region Forecast to 2032

Thermosphere Ablation Technology Market, By Technology (Thermal, Field, and Wavelength Control), By Application (Cardiology, Oncology, Gynaecology, Urology, Dermatology, and Others), By Region Forecast to 2032

Reflux Testing Products Market, By Product Type (pH Monitoring Systems, Impedance Testing Systems, and Others), By Disease Indication (Barrett’s esophagus, Reflux esophagitis, and Others), By End-Use, and By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Explore Our Blogs and Insights Section:

Explore Our Japanese Version:  Peripheral Vascular and Biliary Stents Market

Read our Press Release @

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy